Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

Authors
Publication date
1 January 2019
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Pamukkale Üniversitesi Açık Erişim Arşivi

      redirect
      oaioai:acikerisim.pau.edu.tr:1149...
      Last time updated on 27/09/2020